Signals, Powered By EquityPandit
Lupin for treating serious infections has launched Flucytosine capsules, in the American market.
In a regulatory filing, Lupin stated that, the company has launched its generic product in the strengths of 250 mg and 500 mg, after it has received approval from the US Food and Drug Administration (USFDA).
Moreover, the product is the generic version of Valeant Pharmaceuticals International Inc’s Ancobon tablets.
